<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>精准医药 &#8211; 元哲咨询</title>
	<atom:link href="https://www.yuanzhezixun.com/tag/jingzhunyiyao/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.yuanzhezixun.com</link>
	<description>行业研究专家</description>
	<lastBuildDate>Tue, 16 Apr 2019 03:21:53 +0000</lastBuildDate>
	<language>zh-Hans</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.yuanzhezixun.com/wp-content/uploads/2021/10/cropped-shcrilogo-c-45x45.jpg</url>
	<title>精准医药 &#8211; 元哲咨询</title>
	<link>https://www.yuanzhezixun.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>全球精准医药市场（2018-2023）</title>
		<link>https://www.yuanzhezixun.com/quanqiujingzhunyiyaoshichang2018-2023/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Tue, 16 Apr 2019 03:21:53 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Almac Group]]></category>
		<category><![CDATA[GE Healthcare]]></category>
		<category><![CDATA[GlaxoSmithKline (GSK)]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Novartis AG.]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Quest Diagnostics]]></category>
		<category><![CDATA[Randox Laboratories]]></category>
		<category><![CDATA[Teva Pharmaceutical industries]]></category>
		<category><![CDATA[精准医药]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=19051</guid>

					<description><![CDATA[全球精准医药市场受益于生命科学行业的进步。尽管处于初期阶段，但由于有可能治疗和治疗慢性疾病，因此靶向治疗在未来几年中有很大的机会成功取得巨大成功。因此预计2018年至2023年期间市场将以11.60％的复合年增长率（CAGR）扩张，到2023年将产生88.25亿美元的收入。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>2018-2023全球精准医药市场</title>
		<link>https://www.yuanzhezixun.com/2018-2023quanqiujingzhunyiyaoshichang/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Wed, 07 Nov 2018 07:06:00 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[精准医药]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=16495</guid>

					<description><![CDATA[全球精准医药市场的复合年增长率（CAGR）预计将达到12.71％，到2023年的市场规模将超过96.07亿美元。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
